GlassScriptPhysician profile
Melody Wicks
NPI 1609237403
$1,372.54
in general payments reported to CMS, 2019-2025
19 companies · $816 in 2025
The $816 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $217 · 2024: $339 · 2025: $816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,372.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $309.14 | 2024-2025 | Erleada, Carvykti, Rybrevant |
| Merck Sharp & Dohme LLC | $267.70 | 2024-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Sumitomo Pharma America, INC. | $245.00 | 2024-2025 | Gemtesa |
| Boston Scientific Corporation | $65.30 | 2024-2025 | Axonics, Ams 700, Spyglass Discover |
| E.R. Squibb & Sons, L.L.C. | $63.63 | 2023 | Pomalyst |
| Endo USA, INC. | $62.32 | 2025 | Aveed, Xiaflex |
| Astrazeneca Pharmaceuticals LP | $42.65 | 2023 | Lynparza, Enhertu |
| Abbvie INC. | $40.09 | 2024-2025 | |
| Seagen INC. | $33.73 | 2023 | Padcev, Adcetris |
| Daiichi Sankyo INC. | $32.96 | 2023 | Enhertu |
| W. L. Gore & Associates, INC. | $29.88 | 2025 | Gore Bio-A Tissue Reinforcement |
| Teleflex LLC | $29.18 | 2025 | Barrigel |
| Urogen Pharma, INC. | $25.50 | 2024 | |
| Novartis Pharmaceuticals Corporation | $25.23 | 2024 | |
| Astellas Pharma US INC | $22.99 | 2023 | Padcev |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $20.73 | 2023 | Tazverik |
| Tolmar, INC. | $20.08 | 2024 | |
| Calyxo, INC. | $18.59 | 2025 | Cvac Aspiration System |
| 180 Medical, INC. | $17.84 | 2025 | Gentlecath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melody Wicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.